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More than 10% of the global human population is now afflicted with kidney stones, which are 
commonly associated with other significant health problems including diabetes, hypertension and 
obesity. Nearly 70% of these stones are primarily composed of calcium oxalate, a mineral previously 
assumed to be effectively insoluble within the kidney. This has limited currently available treatment 
options to painful passage and/or invasive surgical procedures. We analyze kidney stone thin sections 
with a combination of optical techniques, which include bright field, polarization, confocal and super-
resolution nanometer-scale auto-fluorescence microscopy. Here we demonstrate using interdisciplinary 
geology and biology (geobiology) approaches that calcium oxalate stones undergo multiple events of 
dissolution as they crystallize and grow within the kidney. These observations open a fundamentally 
new paradigm for clinical approaches that include in vivo stone dissolution and identify high-frequency 
layering of organic matter and minerals as a template for biomineralization in natural and engineered 
settings.
Kidney stones have been formally studied by western medicine since 18021,2. In 1868, Beale3 reported that urine 
contains suspended crystal sediments of calcium oxalate (CaOx, oxalate of lime) that are “difficult” to dissolve. 
Research then focused on mineralogy, chemistry and protein incorporation as primary controls on stone growth, 
with little evaluation of urine chemistry4–6. These minerals originally form as tetragonal bipyramid crystals of 
CaOx dihydrate (COD; Weddellite; CaC2O4 • 2H2O) that “transform during the partial loss of water” into mono-
clinic lozenge-shaped crystals of CaOx monohydrate (COM; Whewellite; CaC2O4 • H2O)7–9. A third common but 
minor mineral phase in CaOx stones is orthorhombic crystalline uric acid (UA; C5H4N4O3)10. During the 1960s, 
stone research transitioned to focus on the role of 24-hour urine solution chemistry and calculated supersatu-
ration as an index of stone formation risk11. It is now known that a complex variety of factors other than simple 
urine chemistry influence stone formation, including protein degradation products, cellular responses, and even 
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the likely presence of a kidney microbiome12–14. Moreover, a host of complex human health conditions including 
dehydration, pregnancy, diet, diabetes, hypertension, obesity, genetics, and climate12,15 also affects kidney stone 
susceptibility. Thus, current clinical strategies to employ hydration, diet and/or drugs to “correct” urine chemistry 
are at best only partially effective in preventing stone growth.
In the present study, more than 50 CaOx kidney stone fragments, collected from six Mayo Clinic patients dur-
ing standard percutaneous nephrolithotomy (PCNL) procedures, are analyzed. Integrated geology and biology 
(geobiology) techniques are applied within the chronological and spatial framework of crystal growth and strati-
graphic layering patterns (crystalline architecture) that comprise each stone fragment. Bulk mineralogical analyses 
with infrared (IR) spectroscopy confirm that all samples are primarily composed of CaOx (see Methods). We 
analyze ~20 μm-thick stone fragment sections polished on both sides using a wide range of optical microscopy 
(250 nm-resolution), which include brightfield, phase contrast, polarization, single- and two-photon spectral 
confocal, and fluorescence lifetime imaging. In addition, we use Airyscan super-resolution microscopy (~140 
nm-resolution) to bring the optical resolution beyond the diffraction limit of light16–18. To determine mineralogy 
and chemistry in thin section, we use scanning electron microscopy and energy-dispersive x-ray spectroscopy. 
Only stone fragments from patient MP2 contain all events of crystalline architecture collectively identified in all 
six patient specimens. Therefore, we present MP2 as an exemplar of CaOx kidney stone growth.
Our microscopy analyses indicate that extensive and repeated dissolution occurs throughout the growth his-
tory of each stone. This evidence stands in stark contrast to the common perception that kidney stones do not dis-
solve in the human kidney3,12,15. These results suggest multiple novel strategies targeting in vivo dissolution may 
be effective in alleviating the adverse health impacts of this increasingly common disease. At the same time, these 
insights broaden and advance our ability to accurately interpret the physical, chemical and biological processes 
that control mineral deposition in a variety of other human diseases, as well as many other natural and engineered 
environments where biomineralization takes place.
Results and Discussion
Historical sequence of events. Distinct stratigraphic layering on the scale of 10’s to 100’s of nano-
meters (nano-layering) is revealed by auto-fluorescence (AF, emission of a specific fluorescence light without 
labels in response to a specific excitation wavelength)16,17 generated by changes in organic matter composition 
(Supplementary Fig. 1). We interpret the crystalline architecture of COD, COM and UA in kidney stones using 
the Law of Superposition (i.e., older layers at the bottom and younger layers at the top), proposed in 1667 by 
Nicholas Steno, a Danish physician and pioneering geobiologist2,19. Our observations are synthesized into a his-
torical sequence of events (HSE, Fig. 1, a paragenetic sequence in geology)20.
The earliest stage of kidney stone growth begins with the precipitation of 5–250 μm-diameter perfectly 
geometrically formed (euhedral) COD and COM with internal concentric zonations consistent with free-floating 
growth in the renal calyx and/or pelvis (i.e., crystalline sediment or crystalluria)(CODFF and COMFF, HSE 1 in 
Figs. 1 and 2a)21,22. The outermost surfaces of larger CODFF have euhedral extensions reflecting crystal twinning21, 
including the adherence of smaller CODFF to other larger CODFF faces23 in the form of aggregates (HSE 2 in 
Figs. 1, 2a and Supplementary Fig. 2a). These outermost surfaces then dissolve (HSE 3 in Figs. 1 and 2a), cutting 
10’s of microns down into internal concentric CODFF layers. Following dissolution, small <5–10 µm-diameter 
COMFF land on and encrust outer CODFF surfaces (Figs. 1c and 2a). The next generation of COM exhibits a dense 
nano-layered cortex (COMC; HSE 4 in Figs. 1, 2a and Supplementary Fig. 2b)24,25 that encrusts both pristine and 
dissolved CODFF surfaces. In addition, some COMFF land on and are then encrusted by the same COMC (HSE 4 
in Figs. 1 and 2a). COMC generally adopts the same crystallographic C-axis orientation as the CODFF and COMFF 
(Fig. 1c) they encrust (syntaxial overgrowths).
The CODFF, COMFF and COMC crystal complex then extensively and repeatedly dissolves (HSE 5 in Figs. 1, 
2a), which is recorded by four types of fabrics that cross-cut the crystalline architecture (Supplementary Fig. 2a–d): 
(1) Micron-sized and larger crystals of CODFF partially dissolve from their center, creating irregular void spaces 
lined with remnants of original CODFF (white arrowheads in Figs. 1c, 2a, Supplementary Fig. 2c). (2) Bulk dissolu-
tion completely removes the original COMC-encrusted CODFF, leaving euhedral mold-shaped void spaces (moldic 
porosity, P in Figs. 1, 2 and Supplementary Fig. 2a–d). (3) Continued bulk dissolution cuts into COMC, creating 
canyon-like void spaces that cross-cut COMC nano-layering (Fig. 2b and Supplementary Fig. 2d. (4) Both irregular 
and euhedral moldic porosity within CODFF, COMFF, and COMC is then partially to completely filled with replace-
ment COM (COMR; HSE 6 in Figs. 1, 2a,b and Supplementary Fig. 2b,c,e–g). In addition, Ångstrom-scale dissolu-
tion and crystallization (mimetic replacement, COMM) of COMC takes place, in which the original fine laminations 
of the cortex are completely to partially preserved (HSE 6 in Figs. 1, 2a and Supplementary Fig. 3).
The final stage of stone growth occurs when three separate stone fragments come into contact, locally dissolve 
at contact points and interlock to create a larger stone complex (Supplementary Fig. 1b,c and Video 1). At pres-
ent, we cannot distinguish if the three stone fragments formed entirely by naturally occurring events within the 
patient’s kidney, or whether they broke apart as a result of previous medical intervention. The margins of each 
fragment are irregular, intertwined and exhibit large-scale 300–400 µm-scale truncation of COMC nano- layering 
(Supplementary Fig. 1b,d). These data indicate that dissolution continues as the margins of the stones come into 
contact. After the fragments merge into a stone complex, COM then grows on some outer stone surfaces as cements 
(COMCE; lime green layers in Supplementary Fig. 1c, labeled COMCE in Fig. 2c and Supplementary Fig. 4a,b), which 
exhibit crystal-face specific differences in organic matter concentrations (sector zoning) (labeled SZ in Fig. 2c and 
Supplementary Fig. 4b)26. Uric acid cement crystals (UACE) then grow on outer surfaces of the stone complex (gray 
layers in Supplementary Fig. 1c, labeled UACE in Fig. 2c and Supplementary Fig. 4a,b). Other outermost COMC 
stone surfaces continue to dissolve and are replaced by COD and COM (CODR and COMR, cyan in Supplementary 
Figs. 1c, 4c–f), which is consistent with previously observed “intimate COD and COM relationships6”.
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CODFF aggregates, which reach 300 µm in diameter (dark blue S3 in Supplementary Fig. 1c), are consist-
ent with previous observations of COD morphology within kidney stones and likely form under hypercalciuric 
conditions27. Their large size requires that crystals aggregate in urine collected in the renal calyx and pelvis as 
opposed to filtrate in the nephron collecting ducts, which only reach ~150 µm in diameter12,15. These large CODFF 
aggregates form the nucleus (nidus) that COMC encrusts (Fig. 1c). The symmetry of the COMC concentric lay-
ering indicates free-floating crystallization while completely bathed in urine. Growth while attached to tissue on 
one side would create discontinuous and asymmetric COMC layering around the CODFF nidus12,15. In addition, 
Figure 1. Historical sequence of events (HSE) constructed from super-resolution auto-fluorescence (SRAF) 
images of the MP2 calcium oxalate (CaOx) kidney stone. (a) The HSE. (b) Sketch depicting individual HSE 
events. (c) Representative SRAF image composed of merged three pseudo-colored red, green and blue (RGB) 
channels. Brightness and contrast of the RGB channel intensities are adjusted to highlight the dark crystalline 
fabrics. Raw images with and without adjustments are presented in Supplementary Fig. 2.
www.nature.com/scientificreports/
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COMFF are observed to have landed on the growing surfaces of COMC. These crystals become entombed in, and 
encrusted by, the concentric COMC nano-layering (Figs. 1c and 2, Supplementary Fig. 4c,d) and are called pro-
trusions28 into COMC.
Figure 2. Evidence for in vivo dissolution and nano-layering from confocal auto-fluorescence (CAF) and SRAF 
imaging of the MP2 CaOx kidney stone. Specific areas of the MP2 stone from which these image enlargements 
are made are shown in Supplementary Fig. 1. (a) Tiled CAF image of merged pseudo-colored RGB channels with 
no image adjustments. (b,c) SRAF images of merged pseudo-colored RGB channels. The brightness and contrast of 
each image is individually adjusted to highlight the layered crystalline architecture (raw images with and without 
adjustments are presented in Supplementary Fig. 22). (d) SRAF image of COMC nano-layering from merged 
two-channel blue and red (pseudo-colored cyan) channels (Z-stack optical sections of all layers are presented 
in Supplementary Video 2). The SRAF green channel is identical to the red channel (pseudo-colored cyan) and 
therefore not included. (e) Individual ~140 nm-thick dark and light nano-layers (open and closed arrowheads) 
with enlargement (e). Radiating twinned crystals grow with their c-axis oriented perpendicular to each dark or 
light nano-layer (arrows). (f) Black and white circular polarization phase contrast (CPOLPC) image shows COMC 
dark organic matter-rich and light mineral-rich nano-layering with enlargement (g). The original color image 
of the same area is presented in Supplementary Fig. 18. Images (d,e) are displayed with best-fit intensity profiles. 
Images (f,g) are displayed with best-fit intensity profiles after a gamma correction of 0.4.
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The HSE (Fig. 1) of this representative stone has broad implications for understanding the growth history of 
other types of kidney stones, including those that originate in the renal papilla as interstitial deposits of calcium 
phosphate (apatite) called Randall’s plaques, or in the ducts of Bellini called Randall’s plugs29–31. Randall’s plaque 
commonly erupt into the renal calyx and pelvis, or are released through the nephron, and begin to accrete CODFF 
and eventually COMC (HSE 4) while bathed in urine12. Instead of the initial stages of apatite nidus growth32, CaOx 
kidney stones in the present study have a nidus composed of free-floating CODFF and COMFF (HSE 1–3, Fig. 1). 
The lack of apatite crystal dissolution fabrics within CODFF and COMC in the MP-series stone fragments implies 
that these CaOx stone fragments likely did not contain a precursor Randall’s plaque or plug nidus.
Kidney stones dissolve In vivo. Results from the current study modify the long-held working assumption 
that COM is strongly insoluble in vivo3,12,15, except perhaps within some individual cell organelles (phagolys-
osomes)33. In addition, although the entombment of organic matter has been previously documented12,15, the 
clinical importance of these biomass-rich nano-layers remains undetermined28. Our results indicate that kidney 
stones repeatedly dissolve in vivo (Figs. 1 and 2, Supplementary Figs. 1–4; summarized as dissolution of CODFF 
outer surfaces [HSE 3], dissolution of CODFF, COMFF and COMC via four types of cross-cutting crystal fabrics 
[HSE 5], and mimetic replacement of COMC by COMM [HSE 6]) and highlight the intrinsic relationship between 
organic-rich and mineral-rich nano-layering.
The repeated dissolution, crystallization and resultant remodeling of crystalline architecture that takes place 
during CaOx stone growth is analogous to the commonly observed post-depositional physical, chemical and 
biological alteration observed in natural mineral deposits (diagenesis)24. The sector zoning in COMCE indicates 
that these crystals may be more soluble and thus more susceptible to diagenesis than expected with respect to 
calculated urine supersaturation states25, as controlled by the differential entrapment of organic matter on specific 
COM crystal faces34,35. The biomolecules present within the human kidney may also play a major role in driving 
the multiple events of dissolution as recorded in the HSE (Fig. 1). These are normal constituents of urine chemical 
composition36, and could plausibly include biomolecules derived from a resident microbial community (microbi-
ome)13. However, the composition and potential effects of these biomolecules are currently unknown37.
COMC nano-layers. We use fast Fourier transform (FFT) frequency analyses to compare the nano-layering 
within individual COMC, CODFF and COMR (Supplementary Fig. 5). Both COMC and CODFF exhibit highest 
frequencies and thinnest nano-layers (Supplementary Fig. 5a–d,g–j). The crystalline architecture of COMC, 
CODFF and COMR exhibit different patterns in three distinct optical modalities applied (POLPC, CPOL, SRAF, 
Supplementary Fig. 11) indicating that multi-modal approaches are required to investigate kidney stone crystal-
line fabrics (Supplementary Fig. 5). Nano-layering is the most volumetrically dominant component of COMC 
(Figs. 1 and 2) and occurs in well-defined organic matter- and mineral-rich couplets12,15,38. However, a compre-
hensive understanding of the mechanisms controlling the abrupt switch between deposition of each organic 
matter-rich and mineral-rich nano-layer is unknown9,28,39,40. Under SRAF imaging, bright AF indicates organic 
matter-rich layers, while dim AF represents the adjacent mineral-rich couplet layers (Fig. 2d,e and Supplementary 
Figs. 5 and 12). In contrast, when observed under transmitted-light polarization and phase contrast (CPOLPC), 
the brighter layers are crystal-rich and the dimmer layers are organic matter-rich (Fig. 2f,g). While SRAF imag-
ing reveals sharp well-defined COMC layer couplets at a spatial resolution as fine as ~140 nm (Fig. 2e), previous 
transmission electron microscopy imaging of other kidney stones has detected even finer layering at ~50 nm in 
thickness41. If these ~50 nm-thick layers are present in the six Mayo Clinic patient stones, they would not have 
been optically resolved with SRAF in the present study, but instead, would optically average into ~140 nm-thick 
layers within each couplet. As a result, the actual number of COMC layer couplets and their frequencies in the 
present study could be a 2–3-fold underestimate. Given these detection limits, the observed COMC is composed 
of ~140–250 nm couplets based on the optical resolution of our microscope system.
An initial interpretation of these COMC couplets (Fig. 2d–g) is that the organic matter-rich nano-layers are 
films of biomolecules (peptides, proteins, etc.) entombed between mineral-rich nano-layers28. Potential reasons 
for these rapid nano-layer shifts might include frequent changes in human host and kidney physiology, urine 
biochemistry and perhaps even microbiome ecology and activity. Alternatively, these layers are also comparable 
to the oscillatory zoning found in many minerals, where it is believed that a kinetic feedback mechanism results 
in periodic oscillations of crystal growth and impurity occlusion independent of biological activity42. Further 
analysis of the composition and concentration of organic matter entrapped in each cortex nano-layer will be 
required to establish a mechanistic hypothesis for their deposition. Since the exact amount of time required to 
form any given kidney stone is difficult to constrain, it is uncertain precisely how long it takes to deposit each 
nano-layer couplet. However, previously published observational data regarding how long it takes CaOx stones 
to grow43,44 implies that several thousands of nano-layers could possibly form within weeks or months. Given 
these rough estimates, each nano-layer may have formed on a sub-daily basis of hours or in some cases even 
minutes. If correct, kidney stones could be “read” in the future under clinical conditions as an unprecedented 
ultrahigh-sensitivity record of in vivo human renal function and dynamic biogeochemical reactions.
Biomineralization in natural and engineered environments. The alternating organic matter- and 
mineral-rich nano-layers comprising COMC are strikingly similar to those seen in other modern and ancient 
sedimentary deposits. These include marine stromatolites, ooids and oyster shells and pearls, as well as terrestrial 
hot-spring travertines and cave speleothems, among many other deposits45–47. Previous geobiology studies of 
these natural deposits have only partially deciphered the relative influence of the physical, chemical and bio-
logical factors that are active at the time of layered deposition. COMC nano-layer couplets represent a previ-
ously unknown template for understanding the mechanisms that fundamentally control shifts between biotic 
and abiotic processes during biomineralization. These mechanisms are directly applicable to understanding 
www.nature.com/scientificreports/
6SCIENTIFIC RepoRtS |  (2018) 8:13731  | DOI:10.1038/s41598-018-31890-9
biomineralized deposits common to other natural and engineered environments in fields that range from envi-
ronmental sustainability and energy production, to medical discovery and space exploration.
BF microscopy with a theoretical optical resolution of approximately 1-μm was used to compare the 
nano-layer couplets in kidney stones (Supplementary Fig. 6a–c,j) with travertine formed within ancient 
Roman aqueducts45,47 (Supplementary Fig. 6d–f,k) and cave limestone deposits (speleothems, Supplementary 
Fig. 6g–i,l)45,46. Out of necessity, these analyses are completed at a micrometer-scale resolution instead of the 
nanometer-scale since the cave and aqueduct systems have orders-of-magnitude higher crystal growth rates 
than those in the kidney (Supplementary Fig. 13). These higher rates of crystal growth dramatically increase 
the thickness of each layer, which makes only one or two layers fill an entire frame at super-resolution, mak-
ing them incompatible for frequency analysis (Supplementary Fig. 13a–d). Requirement of lower magnification 
imaging indicates that CaOx kidney stone layers are 10-times higher frequency (~1.6 µm/layer) than those in the 
cave deposits (~16 µm/layer), and 3-times higher frequency than those in the aqueduct travertine (~5 µm/layer; 
Supplementary Fig. 6m). Although not yet proven, the significantly thinner and higher frequency nano-layers in 
kidney stones (Supplementary Fig. 6) may be the result of the short-time scales over which human renal function 
and biochemistry can change (i.e., seconds to hours). This may also reflect the abundant and diverse sources of 
inhibitors in the renal environment compared to those in other geological and engineered settings. In addition, 
the ~140 nm-scale and finer nano-layering in CaOx kidney stones is significantly smaller than the µm-size of 
whole microbial cells and their associated microbial mats that directly influence layering in other geological 
deposits such as stromatolites45,48. As a result of these size constraints, kidney stone biomineralization must be 
controlled by some combination of human host and/or kidney microbiome derived biomolecules rather than 
whole cells.
CaOx kidney stones occur throughout the animal kingdom49. While euhedral CaOx crystals similar to CODFF 
and COMFF are also common in plants, no COMC has yet been reported50. This lack of COMC in plants likely 
reflects the absence of the type of high flow-through hydrodynamic environment present in the kidney, which is 
required to consistently deliver dissolved ions to the site of COMC crystallization. CaOx crystallization in terres-
trial plants serves to store carbon and H2O for later use in times of reduced carbon availability and drought50,51. 
By analogy, it is also possible that CODFF, COMFF and even COMC crystallization in animals may serve to store 
water for later use when the kidney ecosystem is stressed. In vitro batch reactor experiments52, as well as our own 
microfluidics experimentation (Supplementary Figs. 7 and 17) to test CaOx growth dynamics, have success-
fully grown free-floating polymorphic CODFF, COMFF and their aggregates (equivalent to HSE1, Supplementary 
Fig. 8). While COD-to-COM and apatite-to-COM conversion has been demonstrated convincingly, no previous 
experimentation has grown COMC with nano-layer couplets3,8,53,54.
Clinical and future implications. Human beings almost constantly create urine supersaturated with 
respect to CaOx, yet the question remains as to why only 1 in 11 people actually grow symptomatic kidney 
stones12,15. Our study illustrates that understanding kidney stone growth requires knowledge of not only urine 
chemistry, but also crystalline architecture and chemistry of the stones, as well as the biomolecules derived from 
the host animal, kidney itself and possibly resident microbes. The HSE (Fig. 1a,b) is a new synthesis that identifies 
an unexpected roadmap of therapeutic targets for prevention and treatment, which include: 1) prevent CODFF 
and COMFF aggregation and their twinning; 2) promote and maintain CODFF growth, continue CODFF surface 
dissolution, then completely dissolve CODFF prior to COMC encrustation; 3) periodically induce CODFF growth 
during COMC formation to create layers that can be dissolved; 4) enhance any of the later-stage HSE dissolution 
events; and 5) disrupt crystal, urine and biomolecule components that combine to control the switching between 
organic matter-rich and crystal-rich COMC nano-layers. All of these therapeutic targets would involve the intro-
duction of macromolecules that either inhibit or promote crystal growth and dissolution, and lead to less crystal 
aggregation. The development of tools to read the crystalline architecture of kidney stones in a clinical setting 
would allow rapid evaluation and determination of which of these interventions to pursue. It has been confirmed 
for over a decade that precursor forms of amorphous CaOx exist as they do in calcium carbonate and calcium 
phosphate biomineralization55–57. Through a multi-step process, these amorphous CaOx phases fully transform 
into CaOx crystals. Although they leave behind no obvious record of their existence, clinical interventions target-
ing these early upstream events of biomineralization should also be considered for the treatment of kidney stones 
to target these transient states to destabilize the forming crystals. Taken together, these geobiology approaches 
will also have a transformative impact on the study of gallstones, atherosclerosis, osteoporosis and a variety of 
other human biomineralization conditions that involve multiple events of crystal growth and dissolution.
Methods
Detailed methods are provided online in Supplementary Materials. Study approval. All methods 
reported in this manuscript were carried out in accordance with the basic medical research study, which was 
reviewed and approved by the Mayo Clinic Institutional Review Board (IRB 09-002083), and the outcomes of 
this study will positively affect the future management of kidney stone formers. Written informed consent was 
obtained from all six Mayo Clinic patient participants.
Kidney stone collection and thin sectioning. Kidney stones were collected and analyzed from all six patients 
by a single urologist using standard percutaneous nephrolithotomy (PCNL) procedures under sterile operat-
ing room conditions at the Mayo Clinic in Rochester, Minnesota. A line of section for thin sectioning for each 
stone was carefully selected under a Zeiss Axio Zoom.V16 Microscope (Carl Zeiss, Oberkochen, Germany), 
along the orientation that would exhibit a complete cross-section of earliest-to-latest crystalline stone growth. 
Photographs and descriptions were sent with the six stones to Wagner Petrographic Ltd. in Linden, Utah. Here 
they prepared standard-sized (24 mm × 46 mm), uncovered (no cover slip), doubly polished thin sections. 
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Stones were first vacuum impregnated and then mounted on borate silicate glass slides with clear low-viscosity 
cathodoluminescence-resistant epoxy impregnation to prepare double-sided polished, 20 µm-thick petrographic 
thin sections.
Thin section imaging. Thin sections were imaged on a wide variety of optical modalities (Supplementary 
Fig. 11). A Zeiss Axio Observer system (Carl Zeiss, Oberkochen, Germany) with a Zeiss Axiocam 512 MRc 
was used to capture the BF, POL, PC, POLPC, CPOL, CPOLPC and WAF images across a broad range of mag-
nifications (10x: 0.3 NA; 20x: 0.8 NA; 63x: 1.4 NA; and 100x: 1.46 NA). The objectives used were Plan-Neofluar 
(10x), Plan-Apochromat (20–63x) and alpha Plan-Apochromat (1.46 NA). WAF was acquired in three channels, 
including DAPI, FITC and Rhodamine filters. The confocal auto-fluorescence and Airyscan super-resolution 
nano-layers observed in the samples were investigated and quantified using a Zeiss LSM 880 Laser Scanning 
Microscope with Airyscan Super-Resolution. A spectral confocal system (Zeiss LSM 710) with a spectral PMT 
detector AF emissions and a TPAF spectral imaging, a secondary complementary FLIM technique (Fast FLIM, 
ISS, Champaign, IL) were used to distinguish the AF emissions produced by organic matter trapped within the 
calcium oxalate crystals, from those produced by the epoxy required to impregnate and mount the stones. All 
images were processed using the Zeiss Zen Blue and/or Black software to display either minimum and max-
imum or best-fit properties unless otherwise stated in the figure legends. In addition, red-green-blue (RGB) 
curves were adjusted individually or together to highlight all the crystal intensities in individual frames across 
the whole specimen. Where required, a non-linear gamma correction of 0.45 or 0.70 was applied to enhance faint 
AF crystal intensities in the same Zen program under the spline display mode property and all other corrections 
are presented in the corresponding figure legends themselves. Final images were cropped, resized and assembled 
using Adobe Photoshop (Adobe Systems Inc., San Jose, CA) to fit the required format. Adjustment and correction 
models for all images are reported in Supplementary Figs. 18–22.
Elemental analysis of kidney stones. Elemental analysis of kidney stones was performed under standard Mayo 
Clinic infra-red spectral analyses protocol. To qualitatively determine chemical composition, samples were ana-
lyzed with energy dispersive x-ray spectroscopy (EDXS) using an FEI Quanta FEG 450 FESEM (Hillsboro, OR).
In Vitro COM and COD crystal formation in a microfluidic device. A pilot study of initial kidney stone nidus 
crystal growth (HSE 1, Fig. 1) was conducted using a silica microfluidic device designed with a pore-structure 
design that mimics the renal calyx and pelvis environments. A solution of 0.5% (w/v) of kidney stone particles 
and urine was prepared and injected into the micromodel at a flowrate of 100 µl/h for 24 hrs. After this, a labora-
tory urine solution containing both calcium (Ca2+) and oxalate (C2O42−) concentrations of 1 mM each (pH of 7.2) 
was prepared and injected into the micromodel at a rate of 100 µL/h to promote crystal formation in the micro-
model. CaOx crystal growth was tracked with a Nikon Eclipse Ti-E epi-fluorescent inverted microscope with an 
Andor Zyla color camera attachment. Mineralogy of the COM and COD crystals that precipitated within in the 
micromodel was confirmed with Raman Spectroscopy (LabRam HR Evolution NIR, Horiba Scientific) collected 
between 0–1600 cm−1 with a 532 nm DPSS laser and confirmed with the RRUFF online database.
Data Availability
All raw data images from the microscope and point-by-point Excel spreadsheet data for FFT and line tracing 
graphs can be downloaded from the open access website https://figshare.com from the following links: Main 
Figures Raw Data Link: https://figshare.com/s/d130f7175e0266a62b97. Supplementary Raw Files Link: https://
figshare.com/s/9d68faada43222c96a52.
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